Home NDC 70518-2094 VESIcare
Product NDC 70518-2094
11-digit product format 705182094
Labeler code 70518
Product ID 70518-2094_89809956-6c40-1dd3-e053-2a95a90a6d6d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name solifenacin succinate
Dosage form TABLET, FILM COATED
Route ORAL
Labeler REMEDYREPACK INC.
Application NDA021518
Marketing category NDA
Marketing start 2019-05-21
Marketing end 0000-00-00
Substance SOLIFENACIN SUCCINATE
Active strength 5 mg/1
Pharmacologic classes Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 70518-2094-0 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 70518-2094-0 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 70518-2094-0 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 70518-2094-0 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 70518-2094-0 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 70518-2094-0 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 70518-2094-0 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 70518-2094-0 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 70518-2094-0 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 70518-2094-0 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 70518-2094-0 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 70518-2094-0 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021518-001 VESICARE SOLIFENACIN SUCCINATE 5MG TABLET / ORAL RLD 2004-11-19 N021518-002 VESICARE SOLIFENACIN SUCCINATE 10MG TABLET / ORAL RLD 2004-11-19
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021518-001 VESICARE 5MG TABLET / ORAL RLD 2004-11-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021518-002 VESICARE 10MG TABLET / ORAL RLD 2004-11-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 78 observed states.
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N021518-001 6017927*PED 2019-05-19 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021518-002 6017927*PED 2019-05-19 Pediatric extension 74a2ff9319b5…2019-12-14 00:12 UTC 2019-12 N021518-001 6017927*PED 2019-05-19 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021518-002 6017927*PED 2019-05-19 Pediatric extension 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N021518-001 6017927*PED 2019-05-19 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021518-002 6017927*PED 2019-05-19 Pediatric extension b00525d2431f…2019-07-19 19:46 UTC 2019-07 N021518-001 6017927*PED 2019-05-19 Pediatric extension ea99ee380514…2019-07-19 19:46 UTC 2019-07 N021518-002 6017927*PED 2019-05-19 Pediatric extension ea99ee380514…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join VESIcare SOLIFENACIN SUCCINATE Astellas Pharma US, Inc. 9acee910-cdb2-4052-b8b3-c26aff1c8716 2022-10-31 Warnings, Adverse reactions Exact identifier application applno (NDA): 021518 application number: NDA021518